These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35212878)

  • 41. Opioid prescription by gynecologic oncologists: An analysis of Medicare Part D claims.
    Samuel D; Nevadunsky NS; Miller DT; Isani S; Kuo DYS; Gressel GM
    Curr Probl Cancer; 2021 Apr; 45(2):100655. PubMed ID: 32994074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Opioid Prescribing Patterns Among Facial Plastic and Reconstructive Surgeons in the Medicare Population.
    Barbarite E; Occhiogrosso J; McCarty JC; Lee LN; Hadlock TA; Shaye DA; Gadkaree SK
    Facial Plast Surg Aesthet Med; 2021 Dec; 23(6):401-404. PubMed ID: 33650887
    [No Abstract]   [Full Text] [Related]  

  • 43. Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs.
    Perlis RH; Perlis CS
    PLoS One; 2016; 11(5):e0155474. PubMed ID: 27183221
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of Formulary Exclusions and Restrictions for Opioid Alternatives With Opioid Prescribing Among Medicare Beneficiaries.
    Rao T; Kiptanui Z; Dowell P; Triebwasser C; Alexander GC; Harris I
    JAMA Netw Open; 2020 Mar; 3(3):e200274. PubMed ID: 32119095
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Opioid Prescribing Patterns of Optometrists in the Medicare Part D Database.
    Dryden SC; O'Malley HA; Adams LR; Nix GC; Rho JE; Vacheron AB; Fleming JC; Fowler BT
    Optom Vis Sci; 2022 Jan; 99(1):31-34. PubMed ID: 34882610
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Industry payments and physicians prescriptions: Effect of a payment restriction policy.
    Ansari B
    Soc Sci Med; 2021 Jun; 278():113942. PubMed ID: 33892242
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of Electronic Prescribing of Controlled Substances on Opioid Prescribing: Evidence From I-STOP Program in New York.
    Pylypchuk Y; Parasrampuria S; Smiley C; Searcy T
    Med Care Res Rev; 2022 Feb; 79(1):114-124. PubMed ID: 33703961
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of costs of Medicare Part D prescriptions dispensed at retail and mail order pharmacies.
    Carroll NV
    J Manag Care Spec Pharm; 2014 Sep; 20(9):959-67. PubMed ID: 25166295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Role of Physician Networks and Receipt of Opioid-Related Payments.
    Pope E; Sehgal N
    J Gen Intern Med; 2023 Jun; 38(8):1812-1820. PubMed ID: 36376628
    [TBL] [Abstract][Full Text] [Related]  

  • 50. State Medical Cannabis Laws Associated With Reduction in Opioid Prescriptions by Orthopaedic Surgeons in Medicare Part D Cohort.
    Lopez CD; Boddapati V; Jobin CM; Hickernell TR
    J Am Acad Orthop Surg; 2021 Feb; 29(4):e188-e197. PubMed ID: 32404683
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identifying higher-volume antibiotic outpatient prescribers using publicly available medicare part D data - United States, 2019.
    Gouin KA; Fleming-Dutra KE; Tsay S; Bizune D; Hicks LA; Kabbani S
    Am J Transplant; 2022 Apr; 22(4):1266-1270. PubMed ID: 35373523
    [No Abstract]   [Full Text] [Related]  

  • 52. Five-Year Trends in Payments for Neurologist-Prescribed Drugs in Medicare Part D.
    de Havenon A; Delic A; Dehoney S; Whetman P; Sheibani N; Callaghan B; Ney J; Esper GJ; Magliocco B; Nair KV
    Neurology; 2021 Apr; 96(16):e2132-e2137. PubMed ID: 33692164
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Naloxone Co-prescribing to Patients Receiving Prescription Opioids in the Medicare Part D Program, United States, 2016-2017.
    Jones CM; Compton W; Vythilingam M; Giroir B
    JAMA; 2019 Aug; 322(5):462-464. PubMed ID: 31386124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of Psychotropic and Opioid Prescription Fills Among Community-Dwelling Older Adults With Dementia in the US.
    Maust DT; Strominger J; Bynum JPW; Langa KM; Gerlach LB; Zivin K; Marcus SC
    JAMA; 2020 Aug; 324(7):706-708. PubMed ID: 32808997
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distribution of Opioids by Different Types of Medicare Prescribers.
    Chen JH; Humphreys K; Shah NH; Lembke A
    JAMA Intern Med; 2016 Feb; 176(2):259-61. PubMed ID: 26658497
    [No Abstract]   [Full Text] [Related]  

  • 56. Physician characteristics, industry transfers, and pharmaceutical prescribing: Empirical evidence from medicare and the physician payment sunshine act.
    Brunt CS
    Health Serv Res; 2019 Jun; 54(3):636-649. PubMed ID: 30273976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characteristics of New Opioid Use Among Medicare Beneficiaries: Identifying High-Risk Patterns.
    Raman SR; Bush C; Karmali RN; Greenblatt LH; Roberts AW; Skinner AC
    J Manag Care Spec Pharm; 2019 Sep; 25(9):966-972. PubMed ID: 31456497
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rural/Urban Differences in the Predictors of Opioid Prescribing Rates Among Medicare Part D Beneficiaries 65 Years of Age and Older.
    Shoff C; Yang TC; Kim S
    J Rural Health; 2021 Jan; 37(1):5-15. PubMed ID: 32686205
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Opioid Prescriptions by Orthopaedic Surgeons in a Medicare Population: Recent Trends, Potential Complications, and Characteristics of High Prescribers.
    Boddapati V; Padaki AS; Lehman RA; Lenke LG; Levine WN; Riew KD
    J Am Acad Orthop Surg; 2021 Mar; 29(5):e232-e237. PubMed ID: 32796374
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Receipt of Industry Payments is Associated With Prescribing Promoted Alpha-blockers and Overactive Bladder Medications.
    Modi PK; Wang Y; Kirk PS; Dupree JM; Singer EA; Chang SL
    Urology; 2018 Jul; 117():50-56. PubMed ID: 29680480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.